Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Oxford Optronix Launches Tissue Oxygenation and Blood Flow Monitoring Systems

Published: Monday, July 08, 2013
Last Updated: Monday, July 08, 2013
Bookmark and Share
OxyLite™ Pro and OxyFlo™ Pro systems combine to deliver an advanced and unique tissue vitality monitoring platform.

Oxford Optronix has announced the formal launch of its next-generation OxyLite™ Pro and OxyFlo™ Pro systems for tissue oxygenation and blood flow monitoring - delivering the most advanced tissue vitality monitoring platform on the market.

This latest release marks the third generation of the company’s OxyLite™ and OxyFlo™ brand systems, first launched in 1991.

The OxyLite and OxyFlo systems are unique modular instruments that utilize fibre-optic micro-sensors to provide real-time measurements of local tissue oxygenation (ptiO2), tissue blood perfusion (blood flow) and tissue temperature.

These instruments, which are designed to be used either individually or ‘in-tandem’ for simultaneous measurements of tissue oxygenation, blood flow and temperature, are widely used across the globe in areas of biomedical research concerned with hypoxia and ischaemia.

With oxygen sensors based on optical fluorescence technology - pioneered at Oxford Optronix - OxyLite™ Pro is a two- or four-channel oxygen and temperature monitoring instrument that provides continuous, quantitative and high-sensitivity monitoring of oxygen availability to cells and tissue.

This touch-screen based system is remarkably easy to use and is specifically targeted at oxygen measurements in the physiological range, as well as under conditions of hypoxia, offering application in research areas including tumour oxygen monitoring/angiogenesis; cerebral oxygen monitoring in models of stroke and brain injury; vital organ and muscle tissue monitoring; flap monitoring; ophthalmology; wound healing, fMRI-validation techniques; and in-vitro dissolved oxygen monitoring in cell culture and bioreactors.

OxyFlo™ Pro is the company’s third-generation, two- or four-channel laser-Doppler tissue blood flow monitoring instrument.

Oxford Optronix is a pioneer in the development of laser-Doppler based blood flow monitoring (LDF) technology and its latest touch-screen, high-performance system sets a new standard in sensitivity and ease of use.

An ideal system for measuring changing tissue blood flow in acute experimental models, OxyFlo™ Pro offers applications in peripheral vascular disorders; cerebral perfusion monitoring in models of stroke and brain injury; tumour perfusion monitoring/angiogenesis; blood flow in free flaps and pedicle flaps; wound healing; and gastroenterology.

Commenting on the combined system, Dr Hai-Ling Margaret Cheng of University of Toronto, Hospital for Sick Children in Canada said: “In our studies on the response to gas inhalation in abdominal organs, OxyLite and OxyFlo allowed us to monitor tissue pO2 and perfusion response simultaneously in the liver and kidney. No other minimally invasive system could capture dynamic changes with such fine temporal resolution, and no other system could provide concurrent pO2 and perfusion measurement in multiple tissue regions. Oxford Optronix enabled us to understand the physiological phenomena underlying our magnetic resonance imaging measurements. It is truly a powerful, must-have technology.”

Andy Obeid PhD, CEO of Oxford Optronix added: “The release of our new OxyLite™ Pro and OxyFlo™ Pro systems is the culmination of 5 years of continued product development in this area for us.”

He added: “We work closely with our customers to develop targeted solutions that offer unmatched sensitivity, stability and accuracy coupled with total ease-of-use. The introduction of our third-generation platform, enables us to continue providing the ‘gold-standard’ in tissue vitality monitoring that our customers have come to expect.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Porphyrins as Catalysts in Scalable Organic Reactions
This review covers the most relevant scalable porphyrin-catalysed procedures, showing how these compounds represent broad applications in chemistry.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Genome of 6000-Year-Old Barley Sequenced
Researchers have successfully sequenced the genome of Chalcolithic barley grains for the first time.
3D Models May Yield Ovarian Cancer Insights
Researchers are developing new tools to decipher ovarian cancer developments through a 3D printing technology.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!